Clinical Trials Logo

Ulcer, Gastric clinical trials

View clinical trials related to Ulcer, Gastric.

Filter by:
  • Recruiting  
  • Page 1

NCT ID: NCT06002906 Recruiting - Obesity, Morbid Clinical Trials

The Use of Indocyanine Green to Visualize Blood Flow to the Gastrojejunostomy During Bariatric Surgery.

Start date: January 25, 2023
Phase: Phase 4
Study type: Interventional

This is an interventional pilot study aimed to evaluate the use of NIF imaging as an intraoperative aid to assess the anastomotic blood flow to the gastric pouch and gastrojejunostomy during Roux-en-Y gastric bypass surgery and to determine its long-term impact on the rate of marginal ulceration, leaks and stricture.

NCT ID: NCT05320796 Recruiting - Obesity Clinical Trials

The Bioavailability and Effect on Pouch pH of Esomeprazole After Gastric Bypass

Start date: November 1, 2023
Phase: Phase 4
Study type: Interventional

The objective of this study is to investigate the effect of Esomeprazol administered in tablets (Esomeprazol MUT Sandoz® 40mg) or in solution (Esomeprazol MUT Sandoz® 40mg in 10ml tap water) on acid production in the gastric pouch by measuring the intragastric pH and the serum concentration of esomeprazole.

NCT ID: NCT04845438 Recruiting - Bile Reflux Clinical Trials

Evaluation of Biliary Reflux After Mini-gastric Bypass With Using the Biliary Reflux Index

Start date: December 29, 2020
Phase: N/A
Study type: Interventional

MGB is considered to be the best alternative to Roux-en-Y gastric bypass (RYGB) due to the shorter operation time and fewer possible complications. The purpose of this study was to determine biliary reflux in patients undergoing MGB/OAGB with a hand-sewn gastroenteroanastomosis, and MGB/OAGB with a stapler gastroenteroanastomosis.

NCT ID: NCT04422405 Recruiting - Obesity, Morbid Clinical Trials

Functional Changes in the Stomach and Esophagus After One Anastomosis Gastric Bypass- OAGB

BiFLux
Start date: June 1, 2020
Phase: N/A
Study type: Interventional

Evaluation of the functional changes in the stomach and esophagus of patients undergoing One Anastomosis Gastric Bypass (OAGB)